Stay updated on KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now includes the links 'Check who can join' and 'Find Contact Information' to help users assess eligibility and contact the study team, and the revision history shows a new 'Revision: v3.6.0' entry alongside the removal of the older 'Revision: v3.5.5'.SummaryDifference0.5%

- Check20 days agoChange DetectedThe study record history now shows a new revision entry v3.5.5 and removes the earlier revision v3.5.4 from the list.SummaryDifference0.1%

- Check34 days agoChange DetectedA new revision entry v3.5.4 was added to the study record history. The previous revision v3.5.3 was removed from the listing.SummaryDifference0.1%

- Check56 days agoChange DetectedThe Record History now shows a new revision label, Revision: v3.5.3, replacing Revision: v3.5.2. This update represents a small page version update rather than changes to the trial content.SummaryDifference0.1%

- Check70 days agoChange DetectedThe record history now includes a new revision entry v3.5.2 and removes v3.5.0 from the list.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a new 'Study Status' entry on 2026-03-25 and version 9 on 2026-03-23. Deleted the 2025-05-29 entry.SummaryDifference0.4%

Stay in the know with updates to KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.